ARCHIVES

Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies

This article is from The Cancer Letter archive.

Vol. 36 No. 24 | June 25, 2010

Download PDF Visit The Full Archive

Related Articles

In congress: Senate Committee Approves 7.5 Percent Increase for NIH

July 25, 1997

Coalitions Urges Members To Call, Write, Congress

May 3, 1991

NCI Bid For New Clinical Review Panel Rejects; But Invites Researchers To ‘Submit Best Ideas’

March 8, 1991

Cancer Control RFA Announcements

March 9, 1979

In Brief: Lee Helman To Head NCI Pediatric Branch; HHS to Hear From Academic Health Centers

August 22, 1997

Tobacco Council Awards New Grants

April 18, 1980